Morgan Stanley’s Caribou Biosciences CRBU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$466K	Sell	245,112 -53,344	-18%	-$91.6K	﹤0.01%	5521
2025 Q4	$475K	Sell	298,456 -59,763	-17%	-$125K	﹤0.01%	5547
2025 Q3	$835K	Buy	358,219 +26,738	+8%	+$50.5K	﹤0.01%	5256
2025 Q2	$418K	Sell	331,481 -151,283	-31%	-$149K	﹤0.01%	5545
2025 Q1	$441K	Sell	482,764 -2,266,833	-82%	-$2.95M	﹤0.01%	5384
2024 Q4	$4.37M	Buy	2,749,597 +1,551,432	+129%	+$3.12M	﹤0.01%	4110
2024 Q3	$2.35M	Buy	1,198,165 +579,678	+94%	+$1.19M	﹤0.01%	4531
2024 Q2	$1.01M	Buy	618,487 +203,990	+49%	+$652K	﹤0.01%	4950
2024 Q1	$2.13M	Sell	414,497 -1,795,129	-81%	-$11.1M	﹤0.01%	4534
2023 Q4	$12.7M	Buy	2,209,626 +391,947	+22%	+$1.94M	﹤0.01%	3729
2023 Q3	$8.69M	Buy	1,817,679 +550,946	+43%	+$3.42M	﹤0.01%	3253
2023 Q2	$5.38M	Buy	1,266,733 +17,485	+1%	+$78.6K	﹤0.01%	3713
2023 Q1	$6.63M	Buy	1,249,248 +20,081	+2%	+$125K	﹤0.01%	3537
2022 Q4	$7.72M	Buy	1,229,167 +14,575	+1%	+$130K	﹤0.01%	3326
2022 Q3	$12.8M	Buy	1,214,592 +571,409	+89%	+$5.32M	﹤0.01%	2691
2022 Q2	$3.49M	Buy	643,183 +440,295	+217%	+$3.37M	﹤0.01%	4080
2022 Q1	$1.86M	Buy	202,888 +99,820	+97%	+$1.05M	﹤0.01%	4564
2021 Q4	$1.56M	Buy	103,068 +50,312	+95%	+$978K	﹤0.01%	4763
2021 Q3	$1.26M	Buy	+52,756	New	+$1.29M	﹤0.01%	4893